Смертность в отдаленном периоде достигала 33% (n=3) в течение 12 месяцев. Основными причинами такого исхода являлись нарастающая почечная недостаточность – 10% (n=1) и сердечно-сосудистая недостаточность на фоне кардиальных заболеваний – 10% (n=1), а также дыхательная недостаточность – 10% (n=1). Повторное инфицирование в отдале…[Read more]

(7.2%) and Staphylococcus aureus (6.5%). The trend of resistance of meropenem was declining in P. aeruginosa isolates. Klebsiella sp. as the second most prevalent agent showed a high level of resistance to the studied antibiotics. The antibiogram results for S. aureus isolates showed an increasing trend in MRSA isolates. Conclusion By evaluating…[Read more]

In continuation of our efforts to identify promising antileishmanial agents based on the chroman scaffold, we synthesized several substituted 2H-thiochroman derivatives, including thiochromenes, thichromanones and hydrazones substituted in C-2 or C-3 with carbonyl or carboxyl groups. Thirty-two compounds were thus obtained, characterized, and…[Read more]

In continuation of our efforts to identify promising antileishmanial agents based on the chroman scaffold, we synthesized several substituted 2H-thiochroman derivatives, including thiochromenes, thichromanones and hydrazones substituted in C-2 or C-3 with carbonyl or carboxyl groups. Thirty-two compounds were thus obtained, characterized, and…[Read more]

Epigallocatechin‑3‑gallate (EGCG), a polyphenol present in green tea, exhibits anticancer effects in various types of cancer. A number of studies have focused on the effects of EGCG on lung cancer, but not ovarian cancer. Previous reports have implicated that EGCG suppressed ovarian cancer cell proliferation and induced apoptosis, but its pot…[Read more]

pective, including a service context of good relationships, with person-centred care and an understanding of the complexity of people’s lives. CONCLUSION This is the first meta-ethnography to examine the components of effective problematic substance use treatment from the perspective of those experiencing homelessness. Critical components of…[Read more]

There was considerable variation in costs by cancer site and stage. find more Overall national costs in 2015 were $183 billion and projected to increase 34% to $246 billion by 2030, based only on population growth. Conclusions Phase of care cancer-attributable cost estimates by cancer site and stage are key inputs for simulation models and…[Read more]